Welcome to the Journal of Patient-Reported Outcomes, a premier platform dedicated to advancing the field of health informatics and health information management. Published by SPRINGERNATURE since 2017, this Open Access journal allows researchers and practitioners globally to disseminate vital research findings, ensuring that insights into patient-reported outcomes reach a wider audience without barriers. With its current standing in the Q2 quartile for both Health Informatics and Health Information Management in 2023, it is positioned as a significant contributor to the healthcare research community, ranking 76th out of 138 in Medicine and 34th out of 59 in Health Professions. The journal aims to publish high-quality, peer-reviewed articles that explore innovative methodologies, enhance clinical decision-making, and ultimately improve patient care outcomes. By offering a platform for interdisciplinary collaboration, the Journal of Patient-Reported Outcomes fosters a deeper understanding of patients' perspectives in healthcare, making it an essential resource for researchers, professionals, and students alike.

Welcome to the Journal of Evidence Based Medicine, a premier platform dedicated to advancing the field of health policy and medicine through rigorous research and scholarship. Published by WILEY, this esteemed journal, with an ISSN of 1756-5383 and E-ISSN 1756-5391, is headquartered in the United Kingdom and serves as a pivotal resource for disseminating high-quality evidence-based research. Operating within the converged years from 2008 to 2024, the journal boasts a remarkable standing, achieving a Q1 category ranking in both Health Policy and Medicine (Miscellaneous) for 2023, and ranking #12 out of 310 in the Scopus Ranks for Medicine & Health Policy, placing it in the 96th percentile. This commitment to excellence makes the journal a significant conduit for professionals, researchers, and students who seek to inform their practices with the latest evidence and foster advancements in health policy and medical practice. While currently not open access, the journal maintains a rigorous selection process to ensure the highest standards of publication, appealing to anyone intent on exploring groundbreaking studies that shape the health landscape globally.

BMJ-British Medical Journal, published by the esteemed BMJ PUBLISHING GROUP, is a leading academic journal in the field of medicine, specifically categorized within the top Tier Q1 in Medicine (miscellaneous) based on the 2023 rankings. Recognized for its significant impact, BMJ holds an impressive rank of #15 out of 636 in General Medicine, placing it in the 97th percentile among its peers. With a legacy dating back to 1857, this journal continues to foster critical discussions and disseminate high-quality research aimed at advancing clinical practice and healthcare policy. While currently not an open-access journal, its rigorous peer-review process ensures that every publication meets the highest standards of scientific integrity and relevance. Situated in the heart of London at the British Medical Association House, the BMJ remains an essential resource for researchers, healthcare professionals, and students alike, dedicated to sharing impactful findings and innovative medical insights.

HEALTH TECHNOLOGY ASSESSMENT is a prestigious open-access journal published by the NIHR Journals Library, focusing on advancing the science of health technology assessment through robust research and critical analysis in the fields of Health Policy and Medicine. Since its inception in 2001, this journal has fostered a multidisciplinary approach to evaluating health technologies, offering invaluable insights to researchers, healthcare professionals, and policymakers. With an impressive Q1 ranking in both Health Policy and Medicine (miscellaneous) for 2023, it stands at the forefront of academic discourse, reflecting a high-impact factor and an esteemed reputation within its respective categories. The journal not only publishes original research articles, but also reviews and case studies that illuminate the complexities of health technology in real-world applications. Established and based in the United Kingdom, HEALTH TECHNOLOGY ASSESSMENT strives to encourage evidence-based decision-making, making it an essential resource for anyone committed to enhancing healthcare outcomes through innovative technology assessments.

Annals of General Psychiatry is a leading open-access journal published by BMC, dedicated to advancing the field of psychiatry and mental health. Since its inception in 2005, the journal has provided a robust platform for researchers to disseminate peer-reviewed clinical and experimental studies, case reports, and reviews that address the broad spectrum of psychiatric disorders. With an impressive Q1 ranking in Psychiatry and Mental Health for 2023, and a notable Scopus rank of #128 out of 567 in its category, the journal plays a pivotal role in disseminating high-quality, impactful research within the global scientific community. The open access model guarantees wide visibility and accessibility of research findings, ensuring that professionals, students, and policymakers can utilize the latest advancements in the psychiatric field. The journal's presence from 2002 to 2024 further demonstrates its commitment to contributing valuable insights that are relevant to contemporary challenges in mental health.

The Journal of Vascular Nursing is a premier publication dedicated to advancing the field of vascular nursing, addressing critical issues related to the management and treatment of vascular conditions. Published by Elsevier Science Inc, this esteemed journal boasts an ISSN of 1062-0303 and an E-ISSN of 1532-6578. With a notable impact factor and ranked in the top 39% of journals within the Medical and Surgical Nursing category (Q1), it provides a vital platform for the dissemination of innovative research, clinical practice updates, and evidence-based approaches. Since its inception in 1990, the journal has continued to evolve, offering its readership insights that bridge theory and practice, which are crucial for and beneficial to both seasoned professionals and those entering the field. The Journal of Vascular Nursing is invaluable for anyone invested in enhancing patient outcomes and nursing practices within the realm of vascular health.

Journal for Specialists in Pediatric Nursing, published by WILEY, is a leading academic journal that focuses on advancing the field of pediatric nursing through innovative research and evidence-based practices. With an ISSN of 1539-0136 and an E-ISSN of 1744-6155, this journal has been a vital resource since its inception in 2002, and it continues to provide insights that shape the future of pediatric care. As a Q3 rated journal in the Pediatrics category for 2023, it ranks 14th among 25 in the Nursing and Pediatrics sectors of Scopus, highlighting its importance in disseminating impactful research. The journal aims to foster scholarly dialogue among professionals, researchers, and students by publishing articles that address critical issues in pediatric nursing practice and education. As such, it serves as an essential platform for enhancing the quality of care provided to children and developing the next generation of pediatric nurses. For those seeking to enrich their knowledge and stay abreast of trends, the Journal for Specialists in Pediatric Nursing remains a crucial reference point in the constantly evolving realm of pediatric healthcare.

JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, published by SAGE Publications Ltd, serves as a vital platform in the fields of biochemistry and medicine, showcasing significant research contributions since its inception in 1972. With an Open Access policy implemented in 2012, this journal promotes unrestricted dissemination of knowledge, catering to a global audience and ensuring that critical findings are accessible to researchers, healthcare professionals, and students alike. With an impressive scope spanning diverse biomedical disciplines, the journal ranks in the Q3 quartile for both biochemistry and medicine, affirming its relevance and impact within these evolving fields. Hailing from the United Kingdom, the journal is dedicated to fostering a rich academic dialogue that bridges laboratory discoveries and clinical applications, making it an essential resource for those engaged in international medical research. Its ongoing commitment to excellence is reflected in its convergence until 2024, inviting high-quality submissions that contribute to advancements in medical science.

Journal of Comparative Effectiveness Research is a leading academic journal dedicated to the evaluation of healthcare interventions and practices, published by Becaris Publishing. Since transitioning to a fully Open Access model in 2023, the journal has expanded its accessibility to a global audience of researchers, healthcare professionals, and policy makers. With a focus on comparative effectiveness in health policy, it has achieved a notable ranking of #132 out of 310 in the Scopus category for Medicine and Health Policy, placing it in the 57th percentile for scholarly impact. Operating from the United Kingdom, the journal encompasses research from 2012 to 2024 and firmly establishes itself in the academic landscape as a Q2 journal in the Health Policy category as of 2023. By disseminating high-quality, evidence-based research, the Journal of Comparative Effectiveness Research plays a vital role in informing clinical practice and health policy decision-making, making it an essential resource for those dedicated to improving health outcomes.

Reviews on Recent Clinical Trials, published by Bentham Science Publishers Ltd, is a distinguished journal in the medical and pharmacological fields, assessing the latest advancements in clinical research since its inception in 2006. With a focus on integrating multidisciplinary approaches to evaluating clinical trial methodologies, the journal caters to a diverse audience of researchers, professionals, and students keen on enhancing their knowledge and understanding of innovative therapeutic strategies and drug developments. Notably positioned in the Q3 quartile as ranked by Scopus for both 'Medicine (miscellaneous)' and 'Pharmacology', the journal illustrates a growing academic influence, evidenced by its Scopus rankings—holding a commendable 72nd percentile in general medicine and a 33rd percentile in pharmacology. While the journal is not open access, it remains committed to disseminating high-quality, peer-reviewed content that drives forward the conversation in clinical research. For those interested in staying abreast of novel findings and comprehensive reviews within the clinical trial landscape, Reviews on Recent Clinical Trials stands out as an essential resource.